Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The ISWI ATPase Smarca5 (Snf2h) Is Required for Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells

J. Kokavec, T. Zikmund, F. Savvulidi, V. Kulvait, W. Edelmann, AI. Skoultchi, T. Stopka,

. 2017 ; 35 (6) : 1614-1623. [pub] 20170415

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010759

Grantová podpora
NV16-27790A MZ0 CEP - Centrální evidence projektů

The imitation switch nuclear ATPase Smarca5 (Snf2h) is one of the most conserved chromatin remodeling factors. It exists in a variety of oligosubunit complexes that move DNA with respect to the histone octamer to generate regularly spaced nucleosomal arrays. Smarca5 interacts with different accessory proteins and represents a molecular motor for DNA replication, repair, and transcription. We deleted Smarca5 at the onset of definitive hematopoiesis (Vav1-iCre) and observed that animals die during late fetal development due to anemia. Hematopoietic stem and progenitor cells accumulated but their maturation toward erythroid and myeloid lineages was inhibited. Proerythroblasts were dysplastic while basophilic erythroblasts were blocked in G2/M and depleted. Smarca5 deficiency led to increased p53 levels, its activation at two residues, one associated with DNA damage (S15Ph°s) second with CBP/p300 (K376Ac), and finally activation of the p53 targets. We also deleted Smarca5 in committed erythroid cells (Epor-iCre) and observed that animals were anemic postnatally. Furthermore, 4-hydroxytamoxifen-mediated deletion of Smarca5 in the ex vivo cultures confirmed its requirement for erythroid cell proliferation. Thus, Smarca5 plays indispensable roles during early hematopoiesis and erythropoiesis. Stem Cells 2017;35:1614-1623.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010759
003      
CZ-PrNML
005      
20180419084908.0
007      
ta
008      
180404s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/stem.2604 $2 doi
035    __
$a (PubMed)28276606
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kokavec, Juraj $u BIOCEV, First Faculty of Medicine, Charles University, Czech Republic. Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
245    14
$a The ISWI ATPase Smarca5 (Snf2h) Is Required for Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells / $c J. Kokavec, T. Zikmund, F. Savvulidi, V. Kulvait, W. Edelmann, AI. Skoultchi, T. Stopka,
520    9_
$a The imitation switch nuclear ATPase Smarca5 (Snf2h) is one of the most conserved chromatin remodeling factors. It exists in a variety of oligosubunit complexes that move DNA with respect to the histone octamer to generate regularly spaced nucleosomal arrays. Smarca5 interacts with different accessory proteins and represents a molecular motor for DNA replication, repair, and transcription. We deleted Smarca5 at the onset of definitive hematopoiesis (Vav1-iCre) and observed that animals die during late fetal development due to anemia. Hematopoietic stem and progenitor cells accumulated but their maturation toward erythroid and myeloid lineages was inhibited. Proerythroblasts were dysplastic while basophilic erythroblasts were blocked in G2/M and depleted. Smarca5 deficiency led to increased p53 levels, its activation at two residues, one associated with DNA damage (S15Ph°s) second with CBP/p300 (K376Ac), and finally activation of the p53 targets. We also deleted Smarca5 in committed erythroid cells (Epor-iCre) and observed that animals were anemic postnatally. Furthermore, 4-hydroxytamoxifen-mediated deletion of Smarca5 in the ex vivo cultures confirmed its requirement for erythroid cell proliferation. Thus, Smarca5 plays indispensable roles during early hematopoiesis and erythropoiesis. Stem Cells 2017;35:1614-1623.
650    _2
$a adenosintrifosfatasy $x nedostatek $x metabolismus $7 D000251
650    _2
$a anemie $x patologie $7 D000740
650    _2
$a zvířata $7 D000818
650    _2
$a buněčný cyklus $7 D002453
650    12
$a buněčná diferenciace $7 D002454
650    _2
$a proliferace buněk $7 D049109
650    _2
$a chromozomální proteiny, nehistonové $x nedostatek $x metabolismus $7 D002868
650    _2
$a poškození DNA $x genetika $7 D004249
650    _2
$a erytroidní buňky $x cytologie $7 D041905
650    _2
$a erytropoéza $7 D004920
650    _2
$a delece genu $7 D017353
650    _2
$a genotyp $7 D005838
650    _2
$a hematopoéza $7 D006410
650    _2
$a hematopoetické kmenové buňky $x cytologie $x metabolismus $7 D006412
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    _2
$a messenger RNA $x genetika $x metabolismus $7 D012333
650    _2
$a nádorový supresorový protein p53 $x metabolismus $7 D016159
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Zikmund, Tomas $u BIOCEV, First Faculty of Medicine, Charles University, Czech Republic.
700    1_
$a Savvulidi, Filipp $u BIOCEV, First Faculty of Medicine, Charles University, Czech Republic.
700    1_
$a Kulvait, Vojtech $u BIOCEV, First Faculty of Medicine, Charles University, Czech Republic.
700    1_
$a Edelmann, Winfried $u Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
700    1_
$a Skoultchi, Arthur I $u Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA.
700    1_
$a Stopka, Tomas $u BIOCEV, First Faculty of Medicine, Charles University, Czech Republic.
773    0_
$w MED00004436 $t Stem cells (Dayton, Ohio) $x 1549-4918 $g Roč. 35, č. 6 (2017), s. 1614-1623
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28276606 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180419085009 $b ABA008
999    __
$a ok $b bmc $g 1288244 $s 1007571
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 35 $c 6 $d 1614-1623 $e 20170415 $i 1549-4918 $m Stem cells $n Stem Cells $x MED00004436
GRA    __
$a NV16-27790A $p MZ0
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Možnosti archivace